Follicular Lymphoma with Hyaline-Vascular Castleman Disease-Like Follicles and CD20 Positive Follicular Dendritic Cells
Sergio Pina-Oviedo,Wei Wang,Erin Vicknair,John T. Manning,L. Jeffrey Medeiros
DOI: https://doi.org/10.1016/j.pathol.2017.03.006
IF: 5.335
2017-01-01
Pathology
Abstract:Morphological variants of follicular lymphoma, such as the ‘hyaline-vascular Castleman disease-like variant’ and the ‘sclerotic variant’, are rare.1Nozawa Y. Hirao M. Kamimura K. et al.Unusual case of follicular lymphoma with hyaline-vascular follicles.Pathol Int. 2002; 52: 794-795Crossref PubMed Scopus (6) Google Scholar, 2Kojima M. Matsumoto M. Miyazawa Y. et al.Follicular lymphoma with prominent sclerosis (“sclerosing variant of follicular lymphoma”) exhibiting a mesenteric bulky mass resembling inflammatory pseudotumor. Report of three cases.Pathol Oncol Res. 2007; 13: 74-77Crossref PubMed Scopus (7) Google Scholar, 3Siddiqi I.N. Brynes R.K. Wang E. B-cell lymphoma with hyaline vascular Castleman disease-like features.Am J Clin Pathol. 2011; 135: 901-904Crossref PubMed Scopus (18) Google Scholar Here we present a case of follicular lymphoma with hyaline-vascular Castleman disease-like follicles, CD20 positive follicular dendritic cells and peculiar fibrosis of the lymph node stroma with associated vascular proliferation. A 56-year-old man presented with abdominal and back pain for 1 month. Physical examination and laboratory tests were within normal limits. A computed tomography scan showed bulky lymphadenopathy and a retroperitoneal mass (13.2 × 9.8 cm) encasing the aorta and the third portion of the duodenum. The patient underwent excisional biopsy of an enlarged mesenteric lymph node adjacent to the main mass. The lymph node showed effacement of the normal architecture by lymphoid nodules of variable size (Fig. 1A). The lymphoid nodules surrounded atrophic follicle centres mimicking mantle zones. The small atrophic follicle centres were depleted of lymphocytes and consisted predominantly of dendritic cells and endothelial cells (Fig. 1B). The lymphoid nodules were composed mainly of centrocytes with 1–3 centroblasts per high power field and there was no diffuse component. Flow cytometry immunophenotyping showed an aberrant CD10+ B-cell population, positive for cytoplasmic CD22 and CD79a, and negative for surface or cytoplasmic immunoglobulin, CD5, CD19, and CD20. Fluorescence in situ hybridisation (FISH) analysis showed an IGH-BCL2 fusion gene consistent with t(14;18)(q32;q21). Overall, these findings supported the diagnosis of low-grade follicular lymphoma (grade 1 of 3). In addition, the biopsy specimen had some other unusual features. In areas where the lymphoid nodules were not arranged back-to-back, the nodules were separated by fascicles of eosinophilic stroma (Fig. 1A,B). The stromal fascicles approached the lymph node capsule, but the capsule was not thickened. The stroma appeared to be derived from the underlying lymph node stromal network and was composed of capillaries and small arterioles intermixed with cords of spindle and epithelioid cells that showed central oval to reniform nuclei, vesicular chromatin, and abundant eosinophilic cytoplasm consistent with dendritic/stromal cells and macrophages (Fig. 1C). No confluent or solid areas of stromal proliferation were present, and no atypia of stromal cells was identified. In some stromal blood vessels the endothelial lining was plump and the lumina were obliterated. The stroma was sprinkled with small lymphocytes and occasional extravasated red blood cells. The overall features were consistent with stromal fibrosis and vascular proliferation of the stroma which resembled the interfollicular vascular proliferation of hyaline-vascular Castleman disease. Immunohistochemical analysis of the lymphoma showed that the cells were positive for CD10, CD79a, BCL2 and BCL6. These markers exhibited a ‘targetoid’ pattern of labelling with a strong signal in cells surrounding the atrophic follicular centres and weak to no immunoreactivity of cells in the central regions (Fig. 1D). The IgD immunostain was negative in the lymphoma cells and showed that there were no residual mantle zones (Fig. 1D). The CD20 antibody showed weak staining of lymphoma cells, whereas the follicular dendritic cells were strongly positive (Fig. 2A,B). The anti-CD21, CD23 and CD35 antibodies highlighted follicular dendritic cell meshworks within the centre of each lymphoid nodule and were negative in lymphoma cells surrounding these meshworks (Fig. 2C,D). The CD2, CD3, and CD5 immunostains demonstrated abundant interspersed T-cells within the lymphoma nodules (not shown). Cyclin D1 was negative. The Ki-67 proliferation index was approximately 5% in lymphoma cells and negative in the stromal areas. The vascular stroma was negative for all lymphocyte markers and follicular dendritic cell markers and contained a mixture of scattered B and T cells. Based on these findings, we concluded that the follicular lymphoma rimmed atrophic follicle centres imparting an unusual hyaline-vascular Castleman disease-like morphology. Although sporadic reports of follicular lymphoma with hyaline-vascular Castleman disease-like features and follicular lymphoma with prominent sclerosis (‘sclerotic variant’) exist in the literature,1Nozawa Y. Hirao M. Kamimura K. et al.Unusual case of follicular lymphoma with hyaline-vascular follicles.Pathol Int. 2002; 52: 794-795Crossref PubMed Scopus (6) Google Scholar, 2Kojima M. Matsumoto M. Miyazawa Y. et al.Follicular lymphoma with prominent sclerosis (“sclerosing variant of follicular lymphoma”) exhibiting a mesenteric bulky mass resembling inflammatory pseudotumor. Report of three cases.Pathol Oncol Res. 2007; 13: 74-77Crossref PubMed Scopus (7) Google Scholar, 3Siddiqi I.N. Brynes R.K. Wang E. B-cell lymphoma with hyaline vascular Castleman disease-like features.Am J Clin Pathol. 2011; 135: 901-904Crossref PubMed Scopus (18) Google Scholar the instance of follicular lymphoma with hyaline-vascular type Castleman disease-like features and background fibrotic stroma with vascular proliferation is unusual. The combination of ‘atrophic’ lymphoid follicles with apparent prominent mantle zones (which were confirmed to be follicular lymphoma cells) as well as the increased stroma, may cause confusion with the ‘follicular variant’ of hyaline-vascular type Castleman disease. The latter has been defined as hyaline-vascular type Castleman disease containing >50% of lymphoid follicles.4Kojima M. Shimizu K. Ikota H. et al.“Follicular variant” of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.J Clin Exp Hematopathol. 2008; 48: 39-45Crossref PubMed Scopus (11) Google Scholar The lack of an onion skin-like arrangement in the apparent ‘mantle zones’, and the absence of dysplastic follicular dendritic cells and sclerosing blood vessels penetrating into germinal centres in this case argued against the diagnosis of Castleman disease. Another interesting finding is that the immunohistochemical pattern was not typical for conventional follicular lymphoma (CD20 weak in lymphoma cells whereas strong in follicular dendritic cells) (Fig. 2A,B). We confirmed that the CD20 positive follicular dendritic cells showed an identical pattern of labelling and distribution as observed with lineage-specific follicular dendritic cell markers (Fig. 2). The CD20 expression in the follicular dendritic cell meshworks has been observed previously in patients who have received rituximab therapy,5Blieden C. Medeiros L.J. Vega F. Acquired B cell immunophenotype of follicular dendritic cells in a B-cell depleted lymph node after treatment with rituximab.Ann Hematol. 2014; 93: 1947-1948Crossref PubMed Scopus (3) Google Scholar but this patient had not received rituximab at the time of the excisional biopsy. We do not have an explanation for this unusual pattern of CD20 positivity in the follicular dendritic cells. After the diagnosis, the patient was treated with rituximab, cyclophosphamide, daunorubicin, vincristine and prednisone (R-CHOP), and later was switched to therapy with rituximab and bendamustine for several months, but surveillance imaging demonstrated persistent abdominal disease. Eighth months later a biopsy of an abdominal lymph node demonstrated progression to diffuse large B-cell lymphoma positive for IGH-BCL2 by FISH analysis. At the time of this report, the patient is alive and in remission receiving treatment with gemcitabine, dexamethasone and cisplatin and under follow-up. In summary, we present a case of follicular lymphoma with hyaline-vascular type Castleman disease-like features, with an unusual fibrotic background stroma with vascular proliferation and an uncommon distribution of lymphoma cells in a ‘targetoid’ pattern, which raised the diagnostic possibility of hyaline-vascular type Castleman disease. Although rare, these features may create a diagnostic pitfall, particularly in small samples and with limited ancillary testing, with potential clinical implications for treatment. To our knowledge, this constellation of findings is unusual in follicular lymphoma. The mechanisms behind this unique morphological variant are unknown, but might be related to the fact that the excised lymph node was adjacent to a large mesenteric mass, which may have caused vascular obstruction to the lymph node, or might be due to a pre-existing Castleman disease-like process occurring in the lymph node. The authors state that there are no conflicts of interest to disclose.